Summary

Surgical Simulation Market Research Report Information by Model Type (Reality {Synthetic Bench, Cadaveric, Animal, Full Immersion}, Virtual {Augmented Reality, Computer Aided, Others}), by Function (Medical Training, Medical Device Development), by Application (Laparoscopic Surgery, Cardiac Surgery, Gynecological Surgery, Neurological Surgery, Endoscopic Surgery, Others), by End User (Hospitals, Academic & Research Institutes, Surgical Centers, Military Organizations, Medical Device Companies) and by Region (North America, Europe, Asia-Pacific, and the Rest of the World)- Forecast to 2032

Market Overview

The global surgical simulation market was valued at USD 0.39 billion in 2023. The global surgical simulation market is expected to increase from USD 0.45 billion in 2024 to USD 1.5 billion by 2032, with a compound annual growth rate (CAGR) of 14.42% over the forecast period (2024-2032). The global market is developing due to an increased focus on patient safety, a growing elderly population, and technological improvements.
The Surgical Simulation Market is expanding rapidly, thanks to a number of important drivers. One of the primary motivations of this expansion is the growing emphasis on patient safety. According to the World Health Organization (WHO), up to four out of every ten patients worldwide are harmed when receiving outpatient and basic care, with up to 80% of these poor effects preventable. Patient safety is a major concern in the healthcare business. Surgical treatments are inherently risky, and any error or complication can have life-altering or even life-threatening repercussions for patients.
Furthermore, surgical simulators frequently include haptic feedback, which allows trainees to experience tactile sensations during simulated surgeries. This tactile input improves the learning experience by delivering a sense of touch and resistance, similar to what a surgeon would encounter during a real surgery. It enables trainees to develop a delicate and precise touch, which is an essential ability in surgery. The impact of surgical simulation on patient safety goes beyond training. It also plays an important part in R&D. Simulators can be used by researchers to test and perfect new surgical techniques, instruments, and procedures before they are implemented in clinical practice. These reasons are fueling market expansion.

Market Segment insights
The Surgical Simulation Market is divided into two types of models: reality and virtual.
The market has been divided into two segments based on function: medical teaching and medical device development.
The Surgical Simulation Market is divided into several applications, including laparoscopic surgery, cardiac surgery, gynecological surgery, neurological surgery, endoscopic surgery, and others.
The Market has been divided into five end-user segments: hospitals, surgical centers, academic and research institutes, military organizations, and medical device businesses.

Regional insights

The study divides the market into four regions: North America, Europe, Asia-Pacific, and the rest of the world. North America accounted for the biggest market share of more than 39.49% in 2022, owing to early adoption of sophisticated technologies and product innovation by industry participants, which aided market expansion.
The Europe Surgical Simulation market will rise significantly during the projected year, 2024-2032, due to an increase in the use of medical simulation. According to the Global Obesity Observatory 2021 report, 24.5% of men were obese and 43.8% were overweight in Germany in 2020. As a result of these percentages, the estimated National Obesity Risk was 7/10, which was significantly higher and a cause for concern in Germany in 2021. As a result, such a scenario has raised awareness about obesity in Germany, and the majority of people are now opting for less invasive aesthetic treatments to lose weight.
The Asia-Pacific Surgical Simulation market is expected to expand the quickest over the projected period due to rising healthcare expenditure in Asian countries. Furthermore, the government of India required simulation-based instruction in all undergraduate programs. Such government actions will help to strengthen the regional market.

Major Players
Simulab Corporation (US), Surgical Science (Sweden), Mentice (Sweden), VirtaMed AG (Switzerland), 3-Dmed Learning Through Simulation (US), Laerdal Medical (Norway), Gaumard Scientific (US), Materialise (Belgium), Stratasys (Israel), and CAE Inc. (Canada) are among the key companies in the surgical simulation market.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
3.1 OVERVIEW
3.2 DATA FLOW
3.2.1 Data Mining Process
3.3 PURCHASED DATABASE:
3.4 SECONDARY SOURCES:
3.4.1 Secondary Research data flow:
3.5 PRIMARY RESEARCH:
3.5.1 Primary Research DATA FLOW:
3.5.2 Primary Research: Number of Interviews conducted
3.5.3 Primary Research: Regional Coverage
3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
3.6.1 Revenue Analysis Approach
3.7 DATA FORECASTING
3.7.1 Data forecasting Technique
3.8 DATA MODELING
3.8.1 microeconomic factor analysis:
3.8.2 Data modeling:
4 MARKET DYNAMICS
4.1 INTRODUCTION
4.2 DRIVERS
4.2.1 Increasing focus on patient safety
4.2.2 growing geriatric population
4.2.3 Advancements in Technology
4.3 RESTRAINTS
4.3.1 Lack of StandardizatioN
4.4 OPPORTUNITY
4.4.1 Regulatory Support for surgical simulation
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D
5.1.2 Manufacturing
5.1.3 Distribution And Sales
5.1.4 Post-Sales Monitoring
5.2 PORTER’S FIVE FORCES MODEL
5.2.1 Threat of New Entrants
5.2.2 Bargaining Power of Suppliers
5.2.3 Threat of Substitutes
5.2.4 Bargaining Power of Buyers
5.2.5 Intensity of Rivalry
5.3 IMPACT OF COVID-19 ON THE GLOBAL SURGICAL SIMULATION MARKET
5.3.1 impact on supply chain
5.3.2 IMPACT ON KEY PLAYERS
5.3.3 IMPACT ON DEMAND AND SUPPLY
5.4 LATEST APPROACHES IN SURGICAL SIMULATION TRAINING AND DEVICE DEVELOPMENT
5.5 QUALITATIVE ANALYSIS ON CADAVER USE IN SURGICAL SIMULATION
5.5.1 Pricing Analysis
5.5.2 Consumption Analysis
5.6 LIST OF KEY PROVIDERS OF CADAVERS
6 GLOBAL SURGICAL SIMULATION MARKET, BY MODEL TYPE
6.1 OVERVIEW
6.2 REALITY
6.2.1 Synthetic Bench
6.2.2 Cadaveric
6.2.3 Animal
6.2.4 Full Immersion
6.3 VIRTUAL
6.3.1 Augmented Reality
6.3.2 Computer Aided
6.3.3 Others
7 GLOBAL SURGICAL SIMULATION MARKET, BY FUNCTION
7.1 OVERVIEW
7.2 MEDICAL TRAINING
7.3 MEDICAL DEVICE DEVELOPMENT
8 GLOBAL SURGICAL SIMULATION MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 LAPAROSCOPIC SURGERY
8.3 CARDIAC SURGERY
8.4 GYNAECOLOGICAL SURGERY
8.5 NEUROLOGICAL SURGERY
8.6 ENDOSCOPIC SURGERY
8.7 OTHERS
9 GLOBAL SURGICAL SIMULATION MARKET, BY END USER
9.1 OVERVIEW
9.2 HOSPITALS
9.3 ACADEMIC & RESEARCH INSTITUTES
9.4 SURGICAL CENTERS
9.5 MILITARY ORGANIZATIONS
9.6 MEDICAL DEVICE COMPANIES
10 GLOBAL SURGICAL SIMULATION MARKET, BY REGION
10.1 OVERVIEW
10.2 NORTH AMERICA
10.2.1 US
10.2.2 CANADA
10.3 EUROPE
10.3.1 Germany
10.3.2 France
10.3.3 UK
10.3.4 Spain
10.3.5 Italy
10.3.6 Rest of Europe
10.4 ASIA-PACIFIC
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Australia
10.4.6 Rest of Asia-Pacific
10.5 REST OF THE WORLD
10.5.1 Middle East
10.5.2 Africa
10.5.3 Latin America
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 MARKET SHARE ANALYSIS, 2022
11.3 COMPETITOR DASHBOARD
11.4 PUBLIC PLAYERS STOCK SUMMARY
11.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
11.6.1 Product Launch
11.6.2 Partnership/acquisition
11.6.3 Expansion
12 COMPANY PROFILES
12.1 SURGICAL SCIENCE
12.1.1 COMPANY OVERVIEW
12.1.2 FINANCIAL OVERVIEW
12.1.3 Products OFFERed
12.1.4 KEY DEVELOPMENTS
12.1.5 SWOT ANALYSIS
12.1.6 Key Strategy
12.2 MENTICE
12.2.1 COMPANY OVERVIEW
12.2.2 FINANCIAL OVERVIEW
12.2.3 Products OFFERed
12.2.4 KEY DEVELOPMENTS
12.2.5 Key Strategy
12.3 SIMULAB CORPORATION
12.3.1 COMPANY OVERVIEW
12.3.2 FINANCIAL OVERVIEW
12.3.3 PRODUCTS OFFERED
12.3.4 Key developments
12.3.5 KEY STRATEGIES
12.4 VIRTAMED AG
12.4.1 COMPANY OVERVIEW
12.4.2 FINANCIAL OVERVIEW
12.4.3 PRODUCTS OFFERED
12.4.4 KEY DEVELOPMENTS
12.4.5 SWOT ANALYSIS
12.4.6 KEY STRATEGIES
12.5 3-DMED LEARNING THROUGH SIMULATION
12.5.1 COMPANY OVERVIEW
12.5.2 FINANCIAL OVERVIEW
12.5.3 PRODUCTS OFFERED
12.5.4 KEY DEVELOPMENTS
12.5.5 KEY STRATEGIES
12.6 LAERDAL MEDICAL
12.6.1 COMPANY OVERVIEW
12.6.2 FINANCIAL OVERVIEW
12.6.3 PRODUCTS OFFERED
12.6.4 KEY DEVELOPMENTS
12.6.5 KEY STRATEGIES
12.7 GAUMARD SCIENTIFIC
12.7.1 COMPANY OVERVIEW
12.7.2 FINANCIAL OVERVIEW
12.7.3 PRODUCTS OFFERED
12.7.4 KEY DEVELOPMENTS
12.7.5 SWOT ANALYSIS
12.7.6 KEY STRATEGIES
12.8 MATERIALISE
12.8.1 COMPANY OVERVIEW
12.8.2 FINANCIAL OVERVIEW
12.8.3 PRODUCTS OFFERED
12.8.4 KEY DEVELOPMENTS
12.8.5 SWOT ANALYSIS
12.8.6 KEY STRATEGIES
12.9 STRATASYS
12.9.1 COMPANY OVERVIEW
12.9.2 FINANCIAL OVERVIEW
12.9.3 PRODUCTS OFFERED
12.9.4 KEY DEVELOPMENTS
12.9.5 KEY STRATEGIES
12.10 CAE INC
12.10.1 COMPANY OVERVIEW
12.10.2 FINANCIAL OVERVIEW
12.10.3 PRODUCTS OFFERED
12.10.4 KEY DEVELOPMENTS
12.10.5 SWOT ANALYSIS
12.10.6 KEY STRATEGIES